Company profile
ProText Mobility, Inc.
OTC: TXTM · Healthcare · Biotechnology
#1154 of 1,418 Healthcare companies by revenuebottom-decile growth
EA Score
——FH —DQ 14GM —SS 56
v0.1 · 25/100 weight · pillars only
↑ Altman-Z, listing tenure · ↓ balance-sheet leverage, return on assets
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$1.4M
Employees
30
as of 2026-08-22
Market cap
$7.2M
as of 2026-08-22
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$642$6422013
Net income-$1.4M-$1.4M2013
Operating income-$927.3k-$927.3k2013
Total assets$4.5k$4.5k2013
Liabilities$5.7M$5.7M2013
Equity-$5.7M-$5.7M2013
Revenue trend
FY2011 – FY2013 · USD
FY11
FY11
FY12
FY13
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is ProText Mobility, Inc.’s revenue?
ProText Mobility, Inc. booked $642 in FY2013 revenue, contracting 94% year over year — among the slowest-growing Healthcare companies we track, at a -225447.5% net margin.
Peers · Healthcare
Atossa Therapeutics, Inc.30DQuantum Medical Transport, Inc.——Health Discovery Corporation——That Marketing Solution, Inc.——Cannonau Corp.——Ludwig Enterprises, Inc.12DNeighbors
Broward →Key facts
CEOPlooy Du Dylon
SectorHealthcare
IndustryBiotechnology
HeadquartersFort Lauderdale, FL
ExchangeOTC: TXTM
Employees30
IPO date2003-08-19
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.